跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 116 条关于
“GRPR”
全部
116
临床试验
31
药物
74
机构
0
资讯
11
上个月
Novartis Discontinues Phase 2 GRPR-Targeted Radioligand Lu-NeoB in Breast Cancer, Reaffirms Platform Commitment
去年
Novel Radioligand Therapy [177Lu]Lu-NeoB Enters Clinical Testing for Advanced Breast Cancer
去年
Alpha-9 Oncology Secures $175M in Series C Funding to Advance Radiopharmaceutical Pipeline
上个月
Ratio Therapeutics Secures $70M Series C to Advance Radiopharmaceutical Pipeline Led by FAP-Targeted Candidate
去年
RenaissThera Advances AI-Designed Oral Obesity Drug Targeting GIPR to Lead Optimization
去年
Antag Therapeutics Launches First-in-Human Trial of Novel GIPR Antagonist for Obesity Treatment
7个月前
Insilico Medicine's AI-Designed GIPR Antagonist ISM0676 Achieves 31.3% Weight Loss in Preclinical Studies
8个月前
Antag Therapeutics Reports Promising Phase 1 Results for Novel GIPR Antagonist AT7687 in Obesity Treatment
去年
BrightGene's Dual GLP-1R/GIPR Agonist BGM0504 Shows Superior Efficacy to Semaglutide in Phase 2 Diabetes Trial
上个月
Cambridge Scientists Solve GIPR Paradox: Distinct Brain Circuits Explain Why Both Activating and Blocking the Same Receptor Drives Weight Loss
第 1 页,共 2 页
上一页
下一页